Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback